The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.40
Bid: 77.40
Ask: 77.70
Change: 1.00 (1.31%)
Spread: 0.30 (0.388%)
Open: 75.80
High: 77.80
Low: 75.20
Prev. Close: 76.40
CHRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Supplementary Prospectus

18 Feb 2022 14:21

RNS Number : 1762C
Chrysalis Investments Limited
18 February 2022
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

18 February 2022

 

 

Chrysalis Investments Limited (the "Company")

 

Publication of a supplementary Prospectus

 

The Company has today published a supplementary prospectus approved by the Financial Conduct Authority (the "Supplementary Prospectus"). The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules following the publication of the annual audited financial statements for the period ended 30 September 2021.

 

The Supplementary Prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 10 March 2021 (the "Prospectus") in respect of a placing programme to issue up to 600 million ordinary and/or C Shares and launch of an Open Offer, Initial Placing, Intermediaries Offer and Offer for Subscription of new Ordinary Shares.

 

A copy of the Supplementary Prospectus will shortly be available for inspection at the National Storage Mechanism which is located at https://data.fca.org.uk/#/nsm/mationalstoragemechanism.

 

The Supplementary Prospectus is also available in electronic form on the Company's website at http://chrysalisinvestments.co.uk/.

 

Neither the National Storage Mechanism website nor the Company's website nor the content of any website accessible from hyperlinks on those websites (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

Terms used but not defined in this announcement shall have the meanings given to such terms in the Prospectus.

-ENDS-

 

For further information, please contact:

 

Jupiter Asset Management:

Magnus Spence

 

 

 

+44 (0) 20 3817 1325

 

Liberum:

Darren Vickers / Owen Matthews / Chris Clarke

 

+44 (0) 20 3100 2000

Numis Securities Limited:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

 

+44 (0) 1481 749364

 

 

Media Enquiries:

 

Montfort Communications

Charlotte McMullen

 

 

+44 (0) 20 3514 0897

Chrysalis@montfort.london

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

Recipients of this announcement who are considering acquiring Ordinary Shares are reminded that any such acquisition must be made only on the basis of the information contained in the prospectus which may be different from the information contained in this announcement. A subscription for Ordinary Shares is subject to specific legal or regulatory restrictions in certain jurisdictions. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event that there is a violation by any person of such restrictions.

 

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The New Ordinary Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and the New Ordinary Shares may not be offered or sold, directly or indirectly, within the United States except pursuant to an exemption from the registration requirements of the US Securities Act. There will be no public offer of the New Ordinary Shares in the United States.

 

Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

 

Each of Liberum and Numis Securities which are authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or Numis Securities (as applicable) or advice to any other person in relation to the matters contained herein. Neither Liberum, Numis Securities nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for this announcement, its contents or otherwise in connection with it or any other information relating to the Company, whether written, oral or in a visual or electronic format.

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIEALAPFFNAEFA
Date   Source Headline
21st Sep 20222:47 pmRNSHolding(s) in Company
9th Sep 202212:36 pmRNSResearch from QuotedData
2nd Sep 202211:51 amRNSHolding(s) in Company
23rd Aug 20222:10 pmRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSQuarterly NAV Announcement and Trading Update
22nd Jul 202210:49 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSPortfolio Update
11th Jul 20221:17 pmRNSPortfolio Update
30th Jun 20227:00 amRNSInterim Results
7th Jun 20227:00 amRNSNew Independent Valuation Committee
30th May 20227:00 amRNSDirector/PDMR Shareholding
23rd May 20227:00 amRNSQuarterly Net Asset Value and Trading Update
13th May 202211:40 amRNSDirector/PDMR Shareholding
14th Apr 20227:00 amRNSInterim NAV Announcement
17th Mar 202211:34 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSQuarterly NAV Announcement and Trading Update
18th Feb 20222:21 pmRNSPublication of a Supplementary Prospectus
18th Feb 20227:00 amRNSResult of AGM
10th Feb 20224:15 pmRNSDirector/PDMR Shareholding
4th Feb 20224:52 pmRNSCorrection to AGM Resolution No. 11
3rd Feb 20223:19 pmRNSDirector/PDMR Shareholding
1st Feb 20222:06 pmRNSPortfolio Update
1st Feb 20227:00 amRNSNotice of AGM
31st Jan 20224:19 pmRNSHolding(s) in Company
31st Jan 202210:59 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSAnnual Financial Report
16th Dec 202111:24 amRNSHolding(s) in Company
13th Dec 20217:00 amRNSResults of Capital Raise
1st Dec 20217:01 amRNSPrimaryBid Offer
1st Dec 20217:00 amRNSProposed Placing
29th Nov 20217:01 amRNSUpdate on Performance Fee Arrangements
29th Nov 20217:00 amRNSNet Asset Value(s) and Trading Update
18th Oct 20212:39 pmRNSDirector/PDMR Shareholding
18th Oct 20212:36 pmRNSDirector/PDMR Shareholding
11th Oct 20217:00 amRNSDepositary Business Transfer
17th Sep 20211:12 pmRNSHolding(s) in Company
20th Aug 20217:00 amRNSQuarterly NAV Announcement
19th Aug 20217:00 amRNSPortfolio Update
17th Aug 202111:29 amRNSPortfolio Update
5th Aug 20214:33 pmRNSUK Government Engagement
29th Jul 20217:00 amRNSPortfolio Update
7th Jul 202111:58 amRNSPortfolio Update
6th Jul 20217:00 amRNSPortfolio Update
30th Jun 20217:00 amRNSInterim Results to 31 March 2021
29th Jun 20217:00 amRNSPortfolio Update
28th Jun 20217:00 amRNSPortfolio Update
25th Jun 20211:02 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSPortfolio Update
10th Jun 20212:17 pmRNSPortfolio Update
1st Jun 20212:38 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.